TRIB Trinity Biotech plc
5,714
$1.60
$0.0422
(2.71%)
| Watchers | 5,714 |
| 52-Wk Low | $1.49 |
| 52-Wk High | $5.50 |
| Market Cap | $11.96M |
| Volume | 21,038.00 |
| 52-Wk High | $5.50 |
| 52-Wk Low | $1.49 |
Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...GuruFocus • about 2 months ago
Trinity Biotech reveals Q4 results and strategic initiatives amidst a challenging fiscal year, setting the stage for a transformative 2024.Related Stocks: TRIB...
Share to Feed
Related Stocks: NAS:TRIB...
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics...
Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript...
Investment analysts at StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB - Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a...
Trinity Biotech plc (NASDAQ:TRIB Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling...
Conference Call Scheduled for Thursday, April 4, 2024 at 8:00 AM ETDUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the Company ), a leading developer and...
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB Free Report) in a research report released on Friday. The brokerage issued a buy rating on the stock.
Trinity Biotech...
StockNews.com started coverage on shares of Trinity Biotech (NASDAQ:TRIB Free Report) in a report released on Thursday. The brokerage issued a buy rating on the stock.
Trinity Biotech Stock...
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the Company ) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC...